×

Liberia To Receive Zmapp Drug To Treat Ebola Patients

Liberia will receive an untested experimental drug, Zmapp, to treat people infected with Ebola Virus, the Liberian government says. The move came after a request … Continue reading Liberia To Receive Zmapp Drug To Treat Ebola Patients


Nanosilver

EBOLA 1Liberia will receive an untested experimental drug, Zmapp, to treat people infected with Ebola Virus, the Liberian government says.

The move came after a request was sent the US from Liberian President, Ellen Johnson Sirleaf, while medical ethics specialists meet in Geneva to explore the use of such new treatments.

The World Health Organization (WHO), while hosting the meeting said, some 1,013 had died from Ebola in West Africa.

US government officials said their role had been to put Liberian officials in contact with Zmapp maker Mapp Bio-pharmaceutical.

According to the Pharmaceutical company, its supply of the drug was exhausted after its supplies were sent to West Africa, and the drug was “provided at no cost in all cases,” the company added.

Zmapp has been used in US on two aid workers who have shown signs of improvement, and a Roman Catholic priest, infected with Ebola in Liberia, who died on tuesday.

However, the drug has only been tested on monkeys and has not yet been evaluated for safety in humans.

At the end of the WHO’s meeting, the organisation approved the use of untested drugs that had been used for the treatment of Ebola.

Earlier, Ivory Coast had announced that it had banned all passenger flights from the three countries hit the most by the spread of Ebola – Guinea, Liberia and Sierra Leone.